Risperidone and reversible neutropenia: a negative rechallenge.
After 6 weeks of a risperidone rechallenge therapy (2-4 mg/day), no hematological abnormalities were observed in a 26-year-old schizophrenic woman. Two years previously after 9 days of risperidone therapy (2-6 mg/day), the same patient had developed a reversible neutropenia during a cold.
Bondolfi
G
G
Département Universitaire de Psychiatrie Adulte (DUPA), Service Hospitalo-ambulatoire A, Prilly-Lausanne, Switzerland.
Morena
P
P
Dascal
D R
DR
Bertschy
G
G
D000328:Adult; D005260:Female; D006801:Humans; D009503:Neutropenia / Q000139:chemically induced*; D018967:Risperidone / Q000009:adverse effects* / Q000627:therapeutic use*; D012559:Schizophrenia / Q000188:drug therapy*
D018967:Risperidone